| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.22B | +2.2% |
| Cost of Revenue | $623.6M | +1.5% |
| R&D Expense | $161.6M | +2.1% |
| SG&A Expense | $281.5M | +9.0% |
| Operating Income | $118.7M | -9.6% |
| Pre-tax Income | $90.7M | -19.2% |
| Income Tax | $34.8M | +37.0% |
| Net Income | $55.9M | -35.7% |
| EPS (Basic) | $2.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $180.0M | +11.3% |
| Accounts Receivable | $299.7M | +12.3% |
| Current Assets | $937.7M | +4.1% |
| Total Assets | $1.54B | +2.9% |
| Current Liabilities | $650.8M | +5.8% |
| Long-term Debt | $539.5M | +0.2% |
| Total Liabilities | $1.26B | +3.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $155.9M | +14.9% |
| Capital Expenditures | $14.5M | -35.1% |
| Investing Cash Flow | -$14.1M | -175.7% |
| Financing Cash Flow | -$121.4M | -52.0% |
| Free Cash Flow | $141.4M | +24.8% |
| -34.0% |
| EPS (Diluted) | $1.98 | -34.7% |
| Stockholders' Equity |
| $283.7M |
| +0.4% |